Mangiferin attenuates Ang II-induced abdominal aortic aneurysm by blocking Lys591-mediated nuclear translocation of STAT3

This study is the first to demonstrate that mangiferin inhibits AAA by targeting the STAT3-KLF5 axis to stabilize VSMC contractility and survival, placing mangiferin as a novel natural therapeutic candidate for AAA.